臨床コミュニケーション＆コラボレーション市場 : 2029年までの世界予測

出版：MarketsandMarkets（マーケッツアンドマーケッツ）　出版年月：2024年4月

Clinical Communication & Collaboration Market – Global Forecast to 2029

臨床コミュニケーション＆コラボレーション市場 : プラットフォーム (コラボレーション)、コンポーネント (バッジ、ナースコール VOIP、遠隔医療)、導入、用途 (ナースコミュニケーション)、エンドユーザー (病院、ASC)、ビジネスモデル、地域別 – 2029年までの世界予測
Clinical Communication & Collaboration Market by Platform (Collaboration), Component (Badge, Nurse Call VOIP, Telehealth), Deployment, Application (Nurse Communication), End User (Hospital, ASC), Business Model, & Region – Global Forecast to 2029

ページ数	458
図表数	655
価格
シングルユーザライセンス	USD 4,950
マルチユーザライセンス（5名）	USD 6,650
コーポレートライセンス	USD 8,150
エンタープライズサイトライセンス	USD 10,000
種別	英文調査報告書

お問合せ・ご注文　　出版社・価格・納期について

Report Overview

The global Clinical Communication and Collaboration market is projected to reach USD 4.8 Billion by 2029 from USD 2.6 billion in 2024, at a CAGR of 13.2% from 2024 to 2029.

世界の臨床コミュニケーション＆コラボレーション市場は、2024年から2029年までCAGR 13.2%で、2024年の26億米ドルから2029年までに48億米ドルに達すると予測されています。

The growth of the market is fuelled by high prevalence of chronic diseases, need for cost-containment in healthcare delivery, growing geriatric population, and rising prominence of big data and mHelath tools. Moreover, clinical communication solutions for home care providers and nurses significantly reduce the chances of readmissions, thus reducing the overall cost of healthcare services. However, lack of knowledge among traditional healthcare provider and data security issues poses a significant challenge within this market.

“Clinical Communication and Collaboration, software segment to witness the highest growth during the forecast period.”

Based on component, the Clinical Communication and Collaboration market is segmented into Hardware, Software and Services. In 2023, software segment is projected to grow at the highest CAGR during the forecast period. The software segment encompasses of clinical alerting and notification, physician and nurse scheduling systems, telehealth platform, and collaborative care platform. These solutions come with analytics and reporting capabilities, allowing healthcare administrators to track communication patterns, monitor performance metrics, and identify areas for improvement. Continuous innovation is another key factor driving the dominance of software solutions in this market. Moreover, several vendors are regularly introducing new features and functionalities to meet the evolving needs of healthcare providers, staying ahead of the competition and maintaining their market leadership, ultimately driving the growth of this segment throughout the forecast period.

“On-premise model held the largest market share in the Clinical Communication and Collaboration Market .”

Based on deployment, the Clinical Communication and Collaboration market is segmented into on-premise and cloud based model. The on-premise mode of deployment held the largest market share in 2023. As the cost structure associated with on-premise solutions are used by several healthcare organizations, especially those with budget constraints or a preference for capital expenditures over operational expenses. With on-premise deployments, organizations make a one-time upfront investment in hardware and software licenses, avoiding recurring subscription fees typically associated with cloud-based solutions. This cost predictability and control over infrastructure expenditures made on-premise deployments an attractive option for healthcare institutions looking to manage long-term costs effectively.

臨床コミュニケーション＆コラボレーション市場 : 2029年までの世界予測 ecosystem

“Hospital & Clinics segment to register the highest growth in the Clinical Communication and Collaboration market during the forecast period.”

Based on end user, the clinical communication and collaboration solution market is segmented into hospitals and clinics, ambulatory surgical centers, long-term care facilities, nursing centers and other end-users which includes maternity care centers, trauma & emergency care centers. In 2023 the hospital & clincs segment held the largest share among the end users. As clincal communication and collaboration solutions enables healthcare professionals to communicate quickly and efficiently. Whether it’s sending secure messages, making voice or video calls, or accessing patient information in real-time, these platforms facilitate seamless communication among care teams, leading to faster decision-making, improved care coordination, and ultimately, better patient outcomes.

“APAC is estimated to register the highest CAGR during the forecast period.”

In this report, the Clinical Communication and Collaboration market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The clinical communication and collaboration market in APAC is projected to register the highest CAGR rate during the forecast period. The growth of this region is due to rise in government initiatives towards the adoption of clinical communication and collaboration solutions by several healthcare organization. Moreover, increasing healthcare expenditure, developing healthcare infrastructure, rising adoption of HCIT solutions, large patient population, and growing geriatric population are expected to drive the growth of the clinical communication and collaboration market in the Asia Pacific.

Breakdown of supply-side primary interviews, by company type, designation, and region:

By Company Type: Tier 1 (40%), Tier 2 (35%), and Tier 3 (25%)
By Designation: C-level (35%), Director-level (45%), and Others (20%)
By Region: North America (55%), Europe (20%), Asia Pacific (15%), Latin America (5%) and Middle East Africa (5%)

臨床コミュニケーション＆コラボレーション市場 : 2029年までの世界予測 region

List of Companies Profiled in the Report

Avaya LLC (US)
Oracle (US)
Cisco Systems, Inc. (US)
Microsoft Corporation (US)
Baxter International (Hillrom) (US)
symplr (US)
NEC Corporation (Japan)
Spok Inc. (US)
Vocera Communications (Stryker) (US)
Ascom Holding AG (Switzerland)
Everbridge (US)
Hidden Brains InfoTech. (India)
Imprivata, Inc. (US)
CommuniCare Technology, Inc. d/b/a Pulsara (US)
Mobile Heartbeat (C-HCA, Inc.) (US)
OnPage. (US)
HARRIS ONPOINT (US)
Jive Software, LLC (US)
TigerConnect (US)
JCT Healthcare Pty Ltd. (Australia)
Amplion (US)
AndorHealth (US)
PerfectServe, Inc. (US)
QliqSOFT, Inc. (US)
Connexall, GlobeStar Systems Inc. (Canada)
Flatiron Health (New York)

Research Coverage

This report studies the Clinical Communication and Collaboration market based on components, application, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total Clinical Communication and Collaboration market. The report forecasts the revenue of the market segments with respect to five major regions.

Reasons to Buy the Report

This report also includes.

• Analysis of key drivers ( Advantages of clinical communication solutions in enhancing patient care and safety, high prevalence of chronic diseases, growing geriatric population, need for cost-containment in healthcare delivery, rising prominence of big data and mHelath tools), restrains (lack of interoperability, high investment required to build infrastructure), challenges (lack of knowledge among traditional healthcare providers, data security issues), opportunities (rising demand for HCIT globally, growing adoption of EHR) are contributing the growth of the Clinical Communication and Collaboration market.

• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the Clinical Communication and Collaboration market.

• Market Development: Comprehensive information on the lucrative emerging markets, components, application, end-user, and region.

• Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the Clinical Communication and Collaboration market.

• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Clinical Communication and Collaboration Market.

1 INTRODUCTION 64

1.1 STUDY OBJECTIVES 64

1.2 MARKET DEFINITION 64

1.3 INCLUSIONS & EXCLUSIONS 65

1.4 MARKET SCOPE 66

1.4.1 MARKET SEGMENTATION 66

FIGURE 1 CLINICAL COMMUNICATION AND COLLABORATION MARKET: SEGMENTS COVERED 66

1.4.2 REGIONAL SEGMENTATION 67

FIGURE 2 CLINICAL COMMUNICATION AND COLLABORATION MARKET: REGIONS COVERED 67

1.4.3 YEARS CONSIDERED 67

1.4.4 CURRENCY CONSIDERED 68

1.5 STAKEHOLDERS 68

1.6 SUMMARY OF CHANGES 69

1.6.1 RECESSION IMPACT 69

2 RESEARCH METHODOLOGY 70

2.1 RESEARCH DATA 70

FIGURE 3 RESEARCH DESIGN 70

2.1.1 SECONDARY DATA 71

2.1.1.1 Key data from secondary sources 72

2.1.2 PRIMARY DATA 72

FIGURE 4 PRIMARY SOURCES 73

2.1.2.1 Key data from primary sources 74

2.1.2.2 Key industry insights 75

FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY DEMAND SIDE, SUPPLY SIDE, DESIGNATION, AND REGION 75

2.2 RESEARCH DESIGN 76

FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 76

2.3 MARKET SIZE ESTIMATION 76

FIGURE 7 SUPPLY-SIDE MARKET ESTIMATION: REVENUE SHARE ANALYSIS 77

2.3.1 BOTTOM-UP APPROACH 78

FIGURE 8 CLINICAL COMMUNICATION AND COLLABORATION MARKET: BOTTOM-UP APPROACH 78

2.3.2 TOP-DOWN APPROACH 79

FIGURE 9 CLINICAL COMMUNICATION AND COLLABORATION MARKET: TOP-DOWN APPROACH 79

2.3.3 TOP-DOWN APPROACH FOR PARENT MARKET ASSESSMENT 79

2.3.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 79

TABLE 1 FACTOR ANALYSIS TO ESTIMATE OVERALL MARKET TRENDS 80

FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 81

FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 82

2.4 MARKET BREAKDOWN & DATA TRIANGULATION 83

FIGURE 12 DATA TRIANGULATION METHODOLOGY 83

2.5 STUDY ASSUMPTIONS 84

2.5.1 MARKET SIZE ASSUMPTIONS 84

2.5.2 RESEARCH ASSUMPTIONS 84

2.6 RISK ASSESSMENT 85

TABLE 2 CLINICAL COMMUNICATION AND COLLABORATION MARKET: RISK ASSESSMENT 85

2.7 RESEARCH LIMITATIONS 85

2.7.1 METHODOLOGY-RELATED LIMITATIONS 85

2.7.2 SCOPE-RELATED LIMITATIONS 85

2.8 IMPACT OF ECONOMIC RECESSION ON CLINICAL COMMUNICATION AND COLLABORATION MARKET 85

TABLE 3 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 86

TABLE 4 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 86

TABLE 5 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 86

3 EXECUTIVE SUMMARY 87

FIGURE 13 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2024 VS. 2029 (USD MILLION) 87

FIGURE 14 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2024 VS. 2029 (USD MILLION) 88

FIGURE 15 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2024 VS. 2029 (USD MILLION) 89

FIGURE 16 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 90

FIGURE 17 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 91

FIGURE 18 GEOGRAPHICAL SNAPSHOT OF CLINICAL COMMUNICATION AND COLLABORATION MARKET 92

4 PREMIUM INSIGHTS 93

4.1 CLINICAL COMMUNICATION AND COLLABORATION MARKET OVERVIEW 93

FIGURE 19 INCREASING NEED FOR BETTER COMMUNICATION TO DRIVE MARKET 93

4.2 ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT AND COUNTRY (2024) 94

FIGURE 20 JAPAN TO DOMINATE ASIA PACIFIC MARKET IN 2024 94

4.3 CLINICAL COMMUNICATION AND COLLABORATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 95

FIGURE 21 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 95

4.4 CLINICAL COMMUNICATION AND COLLABORATION MARKET: REGIONAL MIX 96

FIGURE 22 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD 96

4.5 CLINICAL COMMUNICATION AND COLLABORATION MARKET: DEVELOPED VS. EMERGING ECONOMIES 96

FIGURE 23 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 96

5 MARKET OVERVIEW 97

5.1 INTRODUCTION 97

5.2 MARKET DYNAMICS 97

FIGURE 24 CLINICAL COMMUNICATION AND COLLABORATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 97

TABLE 6 IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN CLINICAL COMMUNICATION AND COLLABORATION MARKET 98

5.2.1 DRIVERS 98

5.2.1.1 Advantages of clinical communication solutions for better patient care and safety 98

5.2.1.2 Rising prevalence of chronic diseases 99

5.2.1.3 Growing geriatric population in low- and middle-income countries 100

5.2.1.4 Need for cost-containment and improved patient care in healthcare industry 100

5.2.1.5 Rising prominence of big data and mHealth tools 101

5.2.2 RESTRAINTS 101

5.2.2.1 Lack of interoperability 101

5.2.2.2 High investments and lack of IT expertise 102

5.2.3 OPPORTUNITIES 102

5.2.3.1 Rising demand for healthcare IT solutions 102

5.2.3.2 Growing adoption of electronic health records in healthcare delivery processes 103

5.2.4 CHALLENGES 103

5.2.4.1 Lack of IT knowledge among traditional healthcare providers 103

5.2.4.2 Increasing number of data security issues 103

FIGURE 25 US: NUMBER OF DATA BREACHES (JANUARY 2009–NOVEMBER 2023) 104

TABLE 7 LARGEST HEALTHCARE DATA BREACHES GLOBALLY (2015–2023) 104

5.3 INDUSTRY TRENDS 106

5.3.1 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS 106

5.3.2 GROWING DEMAND FOR VALUE-BASED HEALTHCARE 107

5.3.3 RISING ADOPTION OF CLOUD-BASED ALARM MANAGEMENT SOLUTIONS 107

5.4 TECHNOLOGY ANALYSIS 108

5.4.1 KEY TECHNOLOGIES 109

5.4.1.1 Artificial intelligence and machine learning 109

5.4.1.2 Internet of things 109

5.4.1.3 Blockchain technology 109

5.4.2 ADJACENT TECHNOLOGIES 110

5.4.2.1 Electronic health records 110

5.4.2.2 Health information exchange 110

5.5 ECOSYSTEM ANALYSIS 111

FIGURE 26 CLINICAL COMMUNICATION AND COLLABORATION MARKET: ECOSYSTEM MAP 111

5.6 VALUE CHAIN ANALYSIS 111

FIGURE 27 CLINICAL COMMUNICATION AND COLLABORATION MARKET: VALUE CHAIN ANALYSIS 112

5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 112

FIGURE 28 REVENUE SHIFT IN CLINICAL COMMUNICATION AND COLLABORATION MARKET 112

5.8 PORTER’S FIVE FORCES ANALYSIS 113

TABLE 8 CLINICAL COMMUNICATION AND COLLABORATION MARKET: PORTER’S FIVE FORCES ANALYSIS 113

5.9 PRICING ANALYSIS 114

5.9.1 AVERAGE SELLING PRICE TREND, BY REGION 114

5.9.2 INDICATIVE PRICING ANALYSIS, BY COMPONENT 115

TABLE 9 AVERAGE SELLING PRICE OF SUBSCRIPTION-BASED CLINICAL ALARM MANAGEMENT SOLUTIONS 115

TABLE 10 AVERAGE SELLING PRICE OF NURSE CALL SYSTEMS 115

TABLE 11 AVERAGE SELLING PRICE OF CLINICAL ALARM MANAGEMENT SERVICES 116

5.10 REGULATORY LANDSCAPE 116

5.10.1 REGULATORY ANALYSIS 116

5.10.1.1 North America 116

TABLE 12 NORTH AMERICA: REGULATORY ANALYSIS 116

5.10.1.2 Europe 117

TABLE 13 EUROPE: REGULATORY ANALYSIS 117

5.10.1.3 Asia Pacific 117

TABLE 14 ASIA PACIFIC: REGULATORY ANALYSIS 117

5.10.1.4 Middle East & Africa 118

TABLE 15 MIDDLE EAST & AFRICA: REGULATORY ANALYSIS 118

5.10.1.5 Latin America 118

TABLE 16 LATIN AMERICA: REGULATORY ANALYSIS 118

5.10.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 118

TABLE 17 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 119

TABLE 18 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 119

TABLE 19 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 119

TABLE 20 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 120

TABLE 21 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 120

5.11 PATENT ANALYSIS 121

5.11.1 PATENT PUBLICATION TRENDS FOR CLINICAL COMMUNICATION AND COLLABORATION SOLUTIONS 121

FIGURE 29 GLOBAL PATENT PUBLICATION TRENDS IN CLINICAL COMMUNICATION AND COLLABORATION MARKET, 2015–2023 121

5.11.2 JURISDICTION AND TOP APPLICANT ANALYSIS 121

FIGURE 30 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR PATENTS IN CLINICAL COMMUNICATION AND COLLABORATION MARKET (JANUARY 2015–DECEMBER 2023) 122

5.12 KEY CONFERENCES & EVENTS 122

TABLE 22 CLINICAL COMMUNICATION AND COLLABORATION MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, 2024–2025 122

5.13 KEY STAKEHOLDERS & BUYING CRITERIA 123

5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 123

FIGURE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 123

TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 123

5.13.2 KEY BUYING CRITERIA 124

FIGURE 32 KEY BUYING CRITERIA FOR TOP THREE END USERS 124

TABLE 24 KEY BUYING CRITERIA FOR TOP THREE END USERS 124

5.14 USE CASE/CASE STUDY ANALYSIS 125

5.14.1 EMPOWERING HEALTHCARE ORGANIZATIONS TO AUGMENT WORKFLOWS FOR DELIVERING EXCEPTIONAL AND TIMELY PATIENT CARE 125

TABLE 25 CASE 1: ALTERNATE SOLUTIONS TO ENHANCE CARE TEAM COMMUNICATION AND COLLABORATION 125

5.14.2 UNIFYING CLINICAL AND COLLABORATIVE SYSTEMS 126

TABLE 26 CASE 2: UNIFIED AND CLINICAL COLLABORATION PLATFORM TO STREAMLINE WORKFLOWS AND SUPPORT CLINICIANS 126

5.14.3 SECURE AND ROLE-BASED COMMUNICATION THROUGH CLINICAL COMMUNICATION AND COLLABORATION SOLUTIONS 126

TABLE 27 CASE 3: OPTIMIZE COMMUNICATION TO ACCELERATE CARE AND CREATE CAPACITY 126

5.15 END USER ANALYSIS 127

5.15.1 UNMET NEEDS 127

TABLE 28 CLINICAL COMMUNICATION AND COLLABORATION MARKET: UNMET NEEDS 127

5.15.2 END USER EXPECTATIONS 128

TABLE 29 CLINICAL COMMUNICATION AND COLLABORATION MARKET: END-USER EXPECTATIONS 128

5.16 BUSINESS MODELS IN CLINICAL COMMUNICATION AND COLLABORATION MARKET 128

5.16.1 SUBSCRIPTION-BASED MODELS 128

5.16.2 PLATFORM AS A SERVICE 128

5.16.3 FREEMIUM MODELS WITH PREMIUM FEATURES 129

5.16.4 COLLABORATIVE ECOSYSTEMS AND PARTNERSHIPS 129

6 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM 130

6.1 INTRODUCTION 131

TABLE 30 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 131

TABLE 31 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 131

6.2 COLLABORATION PLATFORMS 132

6.2.1 FOCUS ON PATIENT-CENTRIC CARE MODELS AND CARE TEAM COLLABORATION TO DRIVE ADOPTION 132

TABLE 32 COLLABORATION PLATFORMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 132

TABLE 33 COLLABORATION PLATFORMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 133

6.3 MESSAGING PLATFORMS 133

6.3.1 REAL-TIME CLINICAL COMMUNICATION TO IMPROVE HEALTHCARE OUTCOMES 133

TABLE 34 MESSAGING PLATFORMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 134

TABLE 35 MESSAGING PLATFORMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 135

6.4 VOICE COMMUNICATION PLATFORMS 135

6.4.1 NEED FOR IMMEDIATE COMMUNICATION DURING TIME-SENSITIVE HEALTHCARE SCENARIOS TO DRIVE ADOPTION 135

TABLE 36 VOICE COMMUNICATION PLATFORMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 136

TABLE 37 VOICE COMMUNICATION PLATFORMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 137

6.5 OTHER PLATFORMS 137

TABLE 38 OTHER CLINICAL COMMUNICATION & COLLABORATION PLATFORMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 138

TABLE 39 OTHER CLINICAL COMMUNICATION & COLLABORATION PLATFORMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 139

7 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT 140

7.1 INTRODUCTION 141

TABLE 40 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 141

TABLE 41 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 141

7.2 SOFTWARE 142

TABLE 42 CLINICAL COMMUNICATION AND COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 142

TABLE 43 CLINICAL COMMUNICATION AND COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 142

TABLE 44 CLINICAL COMMUNICATION AND COLLABORATION SOFTWARE MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 143

TABLE 45 CLINICAL COMMUNICATION AND COLLABORATION SOFTWARE MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 144

7.2.1 CLINICAL ALERT & NOTIFICATION SOFTWARE 144

7.2.1.1 Reduced communication errors and enhanced safety to drive end user adoption 144

TABLE 46 CLINICAL ALERT & NOTIFICATION SOFTWARE MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 145

TABLE 47 CLINICAL ALERT & NOTIFICATION SOFTWARE MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 146

7.2.2 PHYSICIAN & NURSE SCHEDULING SYSTEMS 146

7.2.2.1 Advanced workforce scheduling and improvements in care access to support demand 146

TABLE 48 PHYSICIAN & NURSE SCHEDULING SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 147

TABLE 49 PHYSICIAN & NURSE SCHEDULING SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 148

7.2.3 TELEHEALTH PLATFORMS 148

7.2.3.1 Synchronous nature and potential to increase healthcare access to drive market 148

TABLE 50 TELEHEALTH PLATFORMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 149

TABLE 51 TELEHEALTH PLATFORMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 150

7.2.4 COLLABORATIVE CARE PLATFORMS 150

7.2.4.1 Need for collaboration, innovation, and patient-centered care delivery to drive collaborative care platform adoption 150

TABLE 52 COLLABORATIVE CARE PLATFORMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 151

TABLE 53 COLLABORATIVE CARE PLATFORMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 152

7.3 HARDWARE 152

TABLE 54 CLINICAL COMMUNICATION AND COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 153

TABLE 55 CLINICAL COMMUNICATION AND COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 153

TABLE 56 CLINICAL COMMUNICATION AND COLLABORATION HARDWARE MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 154

TABLE 57 CLINICAL COMMUNICATION AND COLLABORATION HARDWARE MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 155

7.3.1 NURSE CALL SYSTEMS 155

7.3.1.1 Streamlined communication channel and alert capabilities to support adoption 155

TABLE 58 NURSE CALL SYSTEMS OFFERED BY MARKET PLAYERS 156

TABLE 59 NURSE CALL SYSTEMS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 156

TABLE 60 NURSE CALL SYSTEMS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 157

7.3.2 VOIP HANDSETS 157

7.3.2.1 Improvements in staff communication and reduced errors to drive market 157

TABLE 61 VOIP HANDSETS OFFERED BY MARKET PLAYERS 158

TABLE 62 VOIP HANDSETS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 158

TABLE 63 VOIP HANDSETS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 159

7.3.3 INTERACTIVE WHITEBOARDS 159

7.3.3.1 Advanced visualization capabilities to support clinical decision-making 159

TABLE 64 INTERACTIVE WHITEBOARDS OFFERED BY MARKET PLAYERS 160

TABLE 65 INTERACTIVE WHITEBOARDS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 161

TABLE 66 INTERACTIVE WHITEBOARDS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 162

7.3.4 DEDICATED SMARTPHONES & TABLETS 162

TABLE 67 DEDICATED SMARTPHONES & TABLETS OFFERED BY MARKET PLAYERS 163

TABLE 68 DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 163

TABLE 69 DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 163

TABLE 70 DEDICATED SMARTPHONES & TABLETS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 164

TABLE 71 DEDICATED SMARTPHONES & TABLETS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 165

7.3.4.1 Android 165

7.3.4.1.1 User-friendly interface to bolster attractiveness of android devices 165

TABLE 72 ANDROID-BASED DEDICATED SMARTPHONES & TABLETS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 166

TABLE 73 ANDROID-BASED DEDICATED SMARTPHONES & TABLETS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 167

7.3.4.2 iOS 167

7.3.4.2.1 iOS-based devices to grow at highest rate 167

TABLE 74 IOS-BASED DEDICATED SMARTPHONES & TABLETS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 168

TABLE 75 IOS-BASED DEDICATED SMARTPHONES & TABLETS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 169

7.3.5 BADGES 169

7.3.5.1 Low cost, ease of use, high reliability, and fast response time to drive demand 169

TABLE 76 BADGES OFFERED BY MARKET PLAYERS 170

TABLE 77 BADGES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 171

TABLE 78 BADGES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 172

7.3.6 WEARABLE COMMUNICATION DEVICES 172

7.3.6.1 Enhanced efficiency, accuracy, and responsiveness in clinical settings to drive market 172

TABLE 79 WEARABLE COMMUNICATION DEVICES OFFERED BY MARKET PLAYERS 173

TABLE 80 WEARABLE COMMUNICATION DEVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 173

TABLE 81 WEARABLE COMMUNICATION DEVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 174

7.3.7 WORKSTATIONS ON WHEELS 174

7.3.7.1 Shift to more agile solutions like mobile handsets to limit market for traditional workstations on wheels 174

TABLE 82 WORKSTATIONS ON WHEELS OFFERED BY MARKET PLAYERS 175

TABLE 83 WORKSTATIONS ON WHEELS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 175

TABLE 84 WORKSTATIONS ON WHEELS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 176

7.3.8 DEDICATED DESKTOP COMPUTERS 176

7.3.8.1 Integrated communication systems to register highest growth during forecast period 176

TABLE 85 DEDICATED DESKTOP COMPUTERS OFFERED BY MARKET PLAYERS 177

TABLE 86 DEDICATED DESKTOP COMPUTERS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 177

TABLE 87 DEDICATED DESKTOP COMPUTERS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 178

7.3.9 TWO-WAY RADIOS 178

7.3.9.1 Technology-driven solutions to limit growth of two-way radio devices 178

TABLE 88 TWO-WAY RADIOS OFFERED BY MARKET PLAYERS 179

TABLE 89 TWO-WAY RADIOS MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 179

TABLE 90 TWO-WAY RADIOS MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 180

7.4 SERVICES 180

TABLE 91 CLINICAL COMMUNICATION AND COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 181

TABLE 92 CLINICAL COMMUNICATION AND COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 181

TABLE 93 CLINICAL COMMUNICATION AND COLLABORATION SERVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 182

TABLE 94 CLINICAL COMMUNICATION AND COLLABORATION SERVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 183

7.4.1 IMPLEMENTATION & INTEGRATION SERVICES 183

7.4.1.1 Need for interoperability to support market growth 183

TABLE 95 IMPLEMENTATION & INTEGRATION SERVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 184

TABLE 96 IMPLEMENTATION & INTEGRATION SERVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 185

7.4.2 CONSULTING & TRAINING SERVICES 185

7.4.2.1 Demand for guidance and education on using solutions to drive market 185

TABLE 97 CONSULTING & TRAINING SERVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 186

TABLE 98 CONSULTING & TRAINING SERVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 187

7.4.3 SUPPORT & MAINTENANCE SERVICES 187

7.4.3.1 Increasing adoption of clinical communication solutions by healthcare providers to propel market 187

TABLE 99 SUPPORT & MAINTENANCE SERVICES MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 188

TABLE 100 SUPPORT & MAINTENANCE SERVICES MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 189

8 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL 190

8.1 INTRODUCTION 191

TABLE 101 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODE, 2018–2022 (USD MILLION) 191

TABLE 102 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODE, 2023–2029 (USD MILLION) 191

8.2 ON-PREMISE MODEL 192

8.2.1 ON-PREMISE MODEL TO HOLD LARGEST MARKET SHARE 192

TABLE 103 ON-PREMISE CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 192

TABLE 104 ON-PREMISE CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 193

8.3 CLOUD-BASED MODEL 193

8.3.1 CLOUD-BASED MODEL TO REGISTER HIGHEST GROWTH RATE 193

TABLE 105 CLOUD-BASED CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 194

TABLE 106 CLOUD-BASED CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 195

9 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION 196

9.1 INTRODUCTION 197

TABLE 107 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 197

TABLE 108 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 197

9.2 PHYSICIAN COMMUNICATION 198

9.2.1 NEED FOR EFFECTIVE PHYSICIAN COMMUNICATION FOR SEAMLESS CARE TRANSITIONS TO DRIVE MARKET 198

TABLE 109 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR PHYSICIAN COMMUNICATION, BY COUNTRY, 2018–2022 (USD MILLION) 198

TABLE 110 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR PHYSICIAN COMMUNICATION, BY COUNTRY, 2023–2029 (USD MILLION) 199

9.3 NURSE COMMUNICATION 199

9.3.1 NURSE COMMUNICATION TO REGISTER FASTEST GROWTH 199

TABLE 111 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR NURSE COMMUNICATION, BY COUNTRY, 2018–2022 (USD MILLION) 200

TABLE 112 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR NURSE COMMUNICATION, BY COUNTRY, 2023–2029 (USD MILLION) 201

9.4 LAB & RADIOLOGY COMMUNICATION 201

9.4.1 TIMELY ACCESS TO LAB & DIAGNOSTIC INFORMATION TO DRIVE MARKET 201

TABLE 113 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR LAB & RADIOLOGY COMMUNICATION, BY COUNTRY, 2018–2022 (USD MILLION) 202

TABLE 114 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR LAB & RADIOLOGY COMMUNICATION, BY COUNTRY, 2023–2029 (USD MILLION) 203

9.5 PATIENT COMMUNICATION & EMERGENCY ALERTS 203

9.5.1 NEED FOR FASTER RESPONSE AND EFFECTIVE PATIENT MANAGEMENT TO SUPPORT MARKET GROWTH 203

TABLE 115 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR PATIENT COMMUNICATION & EMERGENCY ALERTS, BY COUNTRY, 2018–2022 (USD MILLION) 204

TABLE 116 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR PATIENT COMMUNICATION & EMERGENCY ALERTS, BY COUNTRY, 2023–2029 (USD MILLION) 205

10 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER 206

10.1 INTRODUCTION 207

TABLE 117 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 207

TABLE 118 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 207

10.2 HOSPITALS & CLINICS 208

10.2.1 HOSPITALS & CLINICS TO HOLD LARGEST MARKET SHARE 208

TABLE 119 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2018–2022 (USD MILLION) 208

TABLE 120 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2029 (USD MILLION) 209

10.3 LONG-TERM CARE FACILITIES 209

10.3.1 INCREASING USE OF TELEHEALTH SOLUTIONS TO DRIVE MARKET 209

TABLE 121 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2018–2022 (USD MILLION) 210

TABLE 122 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2023–2029 (USD MILLION) 211

10.4 AMBULATORY SURGERY CENTERS 211

10.4.1 INCREASING DEMAND FOR SAME-DAY SURGICAL PROCEDURES TO DRIVE MARKET 211

TABLE 123 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018–2022 (USD MILLION) 212

TABLE 124 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2023–2029 (USD MILLION) 213

10.5 NURSING CENTERS 213

10.5.1 GROWING NUMBER OF ILLNESSES TO DRIVE MARKET 213

TABLE 125 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR NURSING CENTERS, BY COUNTRY, 2018–2022 (USD MILLION) 214

TABLE 126 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR NURSING CENTERS, BY COUNTRY, 2023–2029 (USD MILLION) 215

10.6 OTHER END USERS 215

TABLE 127 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2022 (USD MILLION) 216

TABLE 128 CLINICAL COMMUNICATION AND COLLABORATION MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2029 (USD MILLION) 217

11 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY REGION 218

11.1 INTRODUCTION 219

TABLE 129 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY REGION, 2018–2022 (USD MILLION) 219

TABLE 130 CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY REGION, 2023–2029 (USD MILLION) 220

11.2 NORTH AMERICA 220

FIGURE 33 NORTH AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET SNAPSHOT 221

TABLE 131 NORTH AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 222

TABLE 132 NORTH AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 222

TABLE 133 NORTH AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 222

TABLE 134 NORTH AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 223

TABLE 135 NORTH AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 223

TABLE 136 NORTH AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 223

TABLE 137 NORTH AMERICA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 224

TABLE 138 NORTH AMERICA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 224

TABLE 139 NORTH AMERICA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 225

TABLE 140 NORTH AMERICA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 225

TABLE 141 NORTH AMERICA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 225

TABLE 142 NORTH AMERICA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 226

TABLE 143 NORTH AMERICA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 226

TABLE 144 NORTH AMERICA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 227

TABLE 145 NORTH AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 227

TABLE 146 NORTH AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 227

TABLE 147 NORTH AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 228

TABLE 148 NORTH AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 228

TABLE 149 NORTH AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 229

TABLE 150 NORTH AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 229

11.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS 229

11.2.2 US 230

11.2.2.1 Favorable mandates to encourage adoption of telehealth 230

TABLE 151 US: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 231

TABLE 152 US: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 231

TABLE 153 US: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 232

TABLE 154 US: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 232

TABLE 155 US: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 233

TABLE 156 US: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 233

TABLE 157 US: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 234

TABLE 158 US: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 234

TABLE 159 US: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 234

TABLE 160 US: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 235

TABLE 161 US: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 235

TABLE 162 US: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 236

TABLE 163 US: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 236

TABLE 164 US: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 236

TABLE 165 US: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 237

TABLE 166 US: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 237

TABLE 167 US: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 238

TABLE 168 US: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 238

11.2.3 CANADA 238

11.2.3.1 Rising healthcare spending to drive market 238

TABLE 169 CANADA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 239

TABLE 170 CANADA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 239

TABLE 171 CANADA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 240

TABLE 172 CANADA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 240

TABLE 173 CANADA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 241

TABLE 174 CANADA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 241

TABLE 175 CANADA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 242

TABLE 176 CANADA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 242

TABLE 177 CANADA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 242

TABLE 178 CANADA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 243

TABLE 179 CANADA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 243

TABLE 180 CANADA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 244

TABLE 181 CANADA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 244

TABLE 182 CANADA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 244

TABLE 183 CANADA: CLINICAL COMMUNICATION & COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 245

TABLE 184 CANADA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 245

TABLE 185 CANADA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 246

TABLE 186 CANADA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 246

11.3 EUROPE 247

TABLE 187 EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 247

TABLE 188 EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 248

TABLE 189 EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 248

TABLE 190 EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 249

TABLE 191 EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 249

TABLE 192 EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 249

TABLE 193 EUROPE: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 250

TABLE 194 EUROPE: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 250

TABLE 195 EUROPE: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 251

TABLE 196 EUROPE: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 251

TABLE 197 EUROPE: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 251

TABLE 198 EUROPE: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 252

TABLE 199 EUROPE: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 252

TABLE 200 EUROPE: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 253

TABLE 201 EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 253

TABLE 202 EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 253

TABLE 203 EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 254

TABLE 204 EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 254

TABLE 205 EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 255

TABLE 206 EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 255

11.3.1 EUROPE: RECESSION IMPACT ANALYSIS 255

11.3.2 GERMANY 256

11.3.2.1 Government initiatives for modernizing healthcare systems to propel adoption of clinical communication & collaboration systems 256

TABLE 207 GERMANY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 256

TABLE 208 GERMANY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 257

TABLE 209 GERMANY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 257

TABLE 210 GERMANY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 257

TABLE 211 GERMANY: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 258

TABLE 212 GERMANY: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 258

TABLE 213 GERMANY: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 259

TABLE 214 GERMANY: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 259

TABLE 215 GERMANY: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 259

TABLE 216 GERMANY: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 260

TABLE 217 GERMANY: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 260

TABLE 218 GERMANY: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 261

TABLE 219 GERMANY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 261

TABLE 220 GERMANY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 261

TABLE 221 GERMANY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 262

TABLE 222 GERMANY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 262

TABLE 223 GERMANY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 263

TABLE 224 GERMANY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 263

11.3.3 UK 263

11.3.3.1 NHS programs for implementing digital health systems to increase adoption of clinical communication & collaboration solutions 263

TABLE 225 UK: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 264

TABLE 226 UK: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 264

TABLE 227 UK: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 265

TABLE 228 UK: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 265

TABLE 229 UK: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 266

TABLE 230 UK: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 266

TABLE 231 UK: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 267

TABLE 232 UK: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 267

TABLE 233 UK: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 267

TABLE 234 UK: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 268

TABLE 235 UK: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 268

TABLE 236 UK: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 269

TABLE 237 UK: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 269

TABLE 238 UK: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 269

TABLE 239 UK: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 270

TABLE 240 UK: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 270

TABLE 241 UK: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 271

TABLE 242 UK: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 271

11.3.4 FRANCE 271

11.3.4.1 Growing initiatives to promote adoption of healthcare IT solutions to drive market 271

TABLE 243 FRANCE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 272

TABLE 244 FRANCE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 272

TABLE 245 FRANCE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 273

TABLE 246 FRANCE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 273

TABLE 247 FRANCE: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 274

TABLE 248 FRANCE: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 274

TABLE 249 FRANCE: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 275

TABLE 250 FRANCE: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 275

TABLE 251 FRANCE: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 275

TABLE 252 FRANCE: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 276

TABLE 253 FRANCE: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 276

TABLE 254 FRANCE: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 277

TABLE 255 FRANCE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 277

TABLE 256 FRANCE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 277

TABLE 257 FRANCE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 278

TABLE 258 FRANCE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 278

TABLE 259 FRANCE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 279

TABLE 260 FRANCE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 279

11.3.5 SPAIN 279

11.3.5.1 Need for optimizing healthcare workflows to drive market 279

TABLE 261 SPAIN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 280

TABLE 262 SPAIN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 280

TABLE 263 SPAIN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 281

TABLE 264 SPAIN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 281

TABLE 265 SPAIN: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 282

TABLE 266 SPAIN: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 282

TABLE 267 SPAIN: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 283

TABLE 268 SPAIN: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 283

TABLE 269 SPAIN: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 283

TABLE 270 SPAIN: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 284

TABLE 271 SPAIN: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 284

TABLE 272 SPAIN: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 285

TABLE 273 SPAIN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 285

TABLE 274 SPAIN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 285

TABLE 275 SPAIN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 286

TABLE 276 SPAIN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 286

TABLE 277 SPAIN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 287

TABLE 278 SPAIN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 287

11.3.6 ITALY 287

11.3.6.1 Rising geriatric population and increasing prevalence of chronic diseases to drive adoption of communication systems 287

TABLE 279 ITALY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 288

TABLE 280 ITALY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 288

TABLE 281 ITALY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 289

TABLE 282 ITALY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 289

TABLE 283 ITALY: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 290

TABLE 284 ITALY: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 290

TABLE 285 ITALY: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 291

TABLE 286 ITALY: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 291

TABLE 287 ITALY: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 291

TABLE 288 ITALY: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 292

TABLE 289 ITALY: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 292

TABLE 290 ITALY: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 293

TABLE 291 ITALY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 293

TABLE 292 ITALY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 293

TABLE 293 ITALY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 294

TABLE 294 ITALY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 294

TABLE 295 ITALY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 295

TABLE 296 ITALY: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 295

11.3.7 REST OF EUROPE 295

TABLE 297 REST OF EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 296

TABLE 298 REST OF EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 296

TABLE 299 REST OF EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 297

TABLE 300 REST OF EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 297

TABLE 301 REST OF EUROPE: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 298

TABLE 302 REST OF EUROPE: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 298

TABLE 303 REST OF EUROPE: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 299

TABLE 304 REST OF EUROPE: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 299

TABLE 305 REST OF EUROPE: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 299

TABLE 306 REST OF EUROPE: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 300

TABLE 307 REST OF EUROPE: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 300

TABLE 308 REST OF EUROPE: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 301

TABLE 309 REST OF EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 301

TABLE 310 REST OF EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 301

TABLE 311 REST OF EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 302

TABLE 312 REST OF EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 302

TABLE 313 REST OF EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 303

TABLE 314 REST OF EUROPE: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 303

11.4 ASIA PACIFIC 304

FIGURE 34 ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET SNAPSHOT 305

TABLE 315 ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 306

TABLE 316 ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 306

TABLE 317 ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 307

TABLE 318 ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 307

TABLE 319 ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 308

TABLE 320 ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 308

TABLE 321 ASIA PACIFIC: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 309

TABLE 322 ASIA PACIFIC: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 309

TABLE 323 ASIA PACIFIC: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 310

TABLE 324 ASIA PACIFIC: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 310

TABLE 325 ASIA PACIFIC: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 310

TABLE 326 ASIA PACIFIC: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 311

TABLE 327 ASIA PACIFIC: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 311

TABLE 328 ASIA PACIFIC: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 312

TABLE 329 ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 312

TABLE 330 ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 312

TABLE 331 ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 313

TABLE 332 ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 313

TABLE 333 ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 314

TABLE 334 ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 314

11.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS 314

11.4.2 JAPAN 315

11.4.2.1 Well-developed healthcare infrastructure and government initiatives to drive market 315

TABLE 335 JAPAN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 315

TABLE 336 JAPAN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 316

TABLE 337 JAPAN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 316

TABLE 338 JAPAN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 316

TABLE 339 JAPAN: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 317

TABLE 340 JAPAN: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 317

TABLE 341 JAPAN: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 318

TABLE 342 JAPAN: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 318

TABLE 343 JAPAN: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 318

TABLE 344 JAPAN: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 319

TABLE 345 JAPAN: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 319

TABLE 346 JAPAN: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 320

TABLE 347 JAPAN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 320

TABLE 348 JAPAN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 320

TABLE 349 JAPAN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 321

TABLE 350 JAPAN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 321

TABLE 351 JAPAN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 322

TABLE 352 JAPAN: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 322

11.4.3 CHINA 322

11.4.3.1 Large population and high burden of chronic diseases to drive market 322

TABLE 353 CHINA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 323

TABLE 354 CHINA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 323

TABLE 355 CHINA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 324

TABLE 356 CHINA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 324

TABLE 357 CHINA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 325

TABLE 358 CHINA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 325

TABLE 359 CHINA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 326

TABLE 360 CHINA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 326

TABLE 361 CHINA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 326

TABLE 362 CHINA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 327

TABLE 363 CHINA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 327

TABLE 364 CHINA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 328

TABLE 365 CHINA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 328

TABLE 366 CHINA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 328

TABLE 367 CHINA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 329

TABLE 368 CHINA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 329

TABLE 369 CHINA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 330

TABLE 370 CHINA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 330

11.4.4 INDIA 330

11.4.4.1 Improvements in healthcare infrastructure to support market growth 330

TABLE 371 INDIA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 331

TABLE 372 INDIA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 331

TABLE 373 INDIA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 332

TABLE 374 INDIA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 332

TABLE 375 INDIA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 333

TABLE 376 INDIA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 333

TABLE 377 INDIA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 334

TABLE 378 INDIA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 334

TABLE 379 INDIA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 334

TABLE 380 INDIA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 335

TABLE 381 INDIA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 335

TABLE 382 INDIA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 336

TABLE 383 INDIA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 336

TABLE 384 INDIA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 336

TABLE 385 INDIA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 337

TABLE 386 INDIA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 337

TABLE 387 INDIA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 338

TABLE 388 INDIA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 338

11.4.5 REST OF ASIA PACIFIC 338

TABLE 389 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 339

TABLE 390 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 340

TABLE 391 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 340

TABLE 392 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 340

TABLE 393 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 341

TABLE 394 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 341

TABLE 395 REST OF ASIA PACIFIC: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 342

TABLE 396 REST OF ASIA PACIFIC: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 342

TABLE 397 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 342

TABLE 398 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 343

TABLE 399 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 343

TABLE 400 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 344

TABLE 401 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 344

TABLE 402 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 344

TABLE 403 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 345

TABLE 404 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 345

TABLE 405 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 346

TABLE 406 REST OF ASIA PACIFIC: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 346

11.5 LATIN AMERICA 346

TABLE 407 LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 347

TABLE 408 LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 347

TABLE 409 LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 348

TABLE 410 LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 348

TABLE 411 LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 349

TABLE 412 LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 349

TABLE 413 LATIN AMERICA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 350

TABLE 414 LATIN AMERICA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 350

TABLE 415 LATIN AMERICA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 351

TABLE 416 LATIN AMERICA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 351

TABLE 417 LATIN AMERICA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 351

TABLE 418 LATIN AMERICA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 352

TABLE 419 LATIN AMERICA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 352

TABLE 420 LATIN AMERICA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 353

TABLE 421 LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 353

TABLE 422 LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 353

TABLE 423 LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 354

TABLE 424 LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 354

TABLE 425 LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 355

TABLE 426 LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 355

11.5.1 LATIN AMERICA: RECESSION IMPACT ANALYSIS 355

11.5.2 BRAZIL 356

11.5.2.1 Rapid adoption of advanced communication technologies to drive market 356

TABLE 427 BRAZIL: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 356

TABLE 428 BRAZIL: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 357

TABLE 429 BRAZIL: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 357

TABLE 430 BRAZIL: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 357

TABLE 431 BRAZIL: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 358

TABLE 432 BRAZIL: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 358

TABLE 433 BRAZIL: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 359

TABLE 434 BRAZIL: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 359

TABLE 435 BRAZIL: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 359

TABLE 436 BRAZIL: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 360

TABLE 437 BRAZIL: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 360

TABLE 438 BRAZIL: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 361

TABLE 439 BRAZIL: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 361

TABLE 440 BRAZIL: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 361

TABLE 441 BRAZIL: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 362

TABLE 442 BRAZIL: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 362

TABLE 443 BRAZIL: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 363

TABLE 444 BRAZIL: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 363

11.5.3 MEXICO 363

11.5.3.1 Rising patient awareness to support market growth 363

TABLE 445 MEXICO: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 364

TABLE 446 MEXICO: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 364

TABLE 447 MEXICO: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 365

TABLE 448 MEXICO: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 365

TABLE 449 MEXICO: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 366

TABLE 450 MEXICO: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 366

TABLE 451 MEXICO: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 367

TABLE 452 MEXICO: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 367

TABLE 453 MEXICO: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 367

TABLE 454 MEXICO: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 368

TABLE 455 MEXICO: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 368

TABLE 456 MEXICO: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 369

TABLE 457 MEXICO: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 369

TABLE 458 MEXICO: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 369

TABLE 459 MEXICO: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 370

TABLE 460 MEXICO: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 370

TABLE 461 MEXICO: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 371

TABLE 462 MEXICO: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 371

11.5.4 REST OF LATIN AMERICA 371

TABLE 463 REST OF LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 372

TABLE 464 REST OF LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 372

TABLE 465 REST OF LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 373

TABLE 466 REST OF LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 373

TABLE 467 REST OF LATIN AMERICA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 374

TABLE 468 REST OF LATIN AMERICA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 374

TABLE 469 REST OF LATIN AMERICA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 375

TABLE 470 REST OF LATIN AMERICA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 375

TABLE 471 REST OF LATIN AMERICA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 375

TABLE 472 REST OF LATIN AMERICA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 376

TABLE 473 REST OF LATIN AMERICA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 376

TABLE 474 REST OF LATIN AMERICA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 377

TABLE 475 REST OF LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 377

TABLE 476 REST OF LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 377

TABLE 477 REST OF LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 378

TABLE 478 REST OF LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 378

TABLE 479 REST OF LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 379

TABLE 480 REST OF LATIN AMERICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 379

11.6 MIDDLE EAST & AFRICA 379

TABLE 481 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COUNTRY, 2018–2022 (USD MILLION) 380

TABLE 482 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COUNTRY, 2023–2029 (USD MILLION) 380

TABLE 483 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 381

TABLE 484 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 381

TABLE 485 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 382

TABLE 486 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 382

TABLE 487 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 383

TABLE 488 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 383

TABLE 489 MIDDLE EAST & AFRICA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 384

TABLE 490 MIDDLE EAST & AFRICA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 384

TABLE 491 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 384

TABLE 492 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 385

TABLE 493 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 385

TABLE 494 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 386

TABLE 495 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 386

TABLE 496 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 386

TABLE 497 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 387

TABLE 498 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 387

TABLE 499 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 388

TABLE 500 MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 388

11.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT ANALYSIS 388

11.6.2 GCC COUNTRIES 389

11.6.2.1 High prevalence of chronic diseases to drive market growth 389

TABLE 501 GCC COUNTRIES: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 389

TABLE 502 GCC COUNTRIES: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 389

TABLE 503 GCC COUNTRIES: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 390

TABLE 504 GCC COUNTRIES: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 390

TABLE 505 GCC COUNTRIES: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 391

TABLE 506 GCC COUNTRIES: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 391

TABLE 507 GCC COUNTRIES: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 392

TABLE 508 GCC COUNTRIES: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 392

TABLE 509 GCC COUNTRIES: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 392

TABLE 510 GCC COUNTRIES: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 393

TABLE 511 GCC COUNTRIES: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 393

TABLE 512 GCC COUNTRIES: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 394

TABLE 513 GCC COUNTRIES: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 394

TABLE 514 GCC COUNTRIES: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 394

TABLE 515 GCC COUNTRIES: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 395

TABLE 516 GCC COUNTRIES: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 395

TABLE 517 GCC COUNTRIES: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 396

TABLE 518 GCC COUNTRIES: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 396

11.6.3 REST OF MIDDLE EAST & AFRICA 396

TABLE 519 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2018–2022 (USD MILLION) 397

TABLE 520 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY PLATFORM, 2023–2029 (USD MILLION) 397

TABLE 521 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2018–2022 (USD MILLION) 398

TABLE 522 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY COMPONENT, 2023–2029 (USD MILLION) 398

TABLE 523 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 399

TABLE 524 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION & COLLABORATION HARDWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 399

TABLE 525 REST OF MIDDLE EAST & AFRICA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2018–2022 (USD MILLION) 400

TABLE 526 REST OF MIDDLE EAST & AFRICA: DEDICATED SMARTPHONES & TABLETS MARKET, BY TYPE, 2023–2029 (USD MILLION) 400

TABLE 527 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2018–2022 (USD MILLION) 400

TABLE 528 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION & COLLABORATION SOFTWARE MARKET, BY TYPE, 2023–2029 (USD MILLION) 401

TABLE 529 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2018–2022 (USD MILLION) 401

TABLE 530 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION & COLLABORATION SERVICES MARKET, BY TYPE, 2023–2029 (USD MILLION) 402

TABLE 531 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2018–2022 (USD MILLION) 402

TABLE 532 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY DEPLOYMENT MODEL, 2023–2029 (USD MILLION) 402

TABLE 533 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2018–2022 (USD MILLION) 403

TABLE 534 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY APPLICATION, 2023–2029 (USD MILLION) 403

TABLE 535 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2018–2022 (USD MILLION) 404

TABLE 536 REST OF MIDDLE EAST & AFRICA: CLINICAL COMMUNICATION AND COLLABORATION MARKET, BY END USER, 2023–2029 (USD MILLION) 404

12 COMPETITIVE LANDSCAPE 405

12.1 INTRODUCTION 405

12.2 STRATEGIES ADOPTED BY KEY PLAYERS 405

FIGURE 35 KEY STRATEGIES DEPLOYED BY CLINICAL COMMUNICATION AND COLLABORATION PLAYERS 406

12.3 REVENUE SHARE ANALYSIS 407

FIGURE 36 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN CLINICAL COMMUNICATION AND COLLABORATION MARKET, 2019–2023 (USD BILLION) 407

12.4 MARKET SHARE ANALYSIS 407

FIGURE 37 CLINICAL COMMUNICATION AND COLLABORATION MARKET: MARKET SHARE ANALYSIS (2023) 408

TABLE 537 CLINICAL COMMUNICATION AND COLLABORATION MARKET: DEGREE OF COMPETITION 408

12.5 BRAND/PRODUCT COMPARATIVE ANALYSIS 409

FIGURE 38 CLINICAL COMMUNICATION AND COLLABORATION MARKET: TOP TRENDING BRANDS/PRODUCTS 409

12.5.1 CISCO SYSTEMS, INC. (US) 409

12.5.2 ORACLE (US) 409

12.5.3 BAXTER INTERNATIONAL, INC. (HILL-ROM HOLDINGS, INC.) (US) 410

12.5.4 AVAYA LLC (US) 410

12.5.5 SPOK INC. (US) 410

12.6 COMPANY EVALUATION AND FINANCIAL METRICS 411

FIGURE 39 EV/EBITDA OF KEY VENDORS 411

FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF CLINICAL COMMUNICATION AND COLLABORATION VENDORS 411

12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS 412

12.7.1 STARS 412

12.7.2 PERVASIVE PLAYERS 412

12.7.3 EMERGING LEADERS 412

12.7.4 PARTICIPANTS 412

FIGURE 41 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2023) 413

12.7.5 COMPANY FOOTPRINT 414

TABLE 538 CLINICAL COMMUNICATION AND COLLABORATION MARKET: COMPANY FOOTPRINT ANALYSIS 414

TABLE 539 CLINICAL COMMUNICATION AND COLLABORATION MARKET: APPLICATION FOOTPRINT ANALYSIS 415

TABLE 540 CLINICAL COMMUNICATION AND COLLABORATION MARKET: END-USER FOOTPRINT ANALYSIS 416

TABLE 541 CLINICAL COMMUNICATION AND COLLABORATION MARKET: REGIONAL FOOTPRINT ANALYSIS 417

12.8 COMPANY EVALUATION MATRIX: START-UPS/SMES 418

12.8.1 PROGRESSIVE COMPANIES 418

12.8.2 DYNAMIC COMPANIES 418

12.8.3 RESPONSIVE COMPANIES 418

12.8.4 STARTING BLOCKS 418

FIGURE 42 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2023) 419

12.8.5 COMPETITIVE BENCHMARKING 420

TABLE 542 CLINICAL COMMUNICATION AND COLLABORATION MARKET: DETAILED LIST OF KEY START-UPS/SMES 420

TABLE 543 CLINICAL COMMUNICATION AND COLLABORATION MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES 421

12.9 COMPETITIVE SCENARIO 422

12.9.1 PRODUCT/SERVICE/SOLUTION LAUNCHES & ENHANCEMENTS 422

TABLE 544 CLINICAL COMMUNICATION AND COLLABORATION MARKET: PRODUCT/SERVICE/SOLUTION LAUNCHES & ENHANCEMENTS (JANUARY 2021–FEBRUARY 2024) 422

12.9.2 DEALS 423

TABLE 545 CLINICAL COMMUNICATION AND COLLABORATION MARKET: DEALS (JANUARY 2021–FEBRUARY 2024) 423

13 COMPANY PROFILES 424

(Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

13.1 KEY PLAYERS 424

13.1.1 CISCO SYSTEMS, INC. 424

TABLE 546 CISCO SYSTEMS, INC.: COMPANY OVERVIEW 424

FIGURE 43 CISCO SYSTEMS, INC.: COMPANY SNAPSHOT (2023) 425

TABLE 547 CISCO SYSTEMS, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 425

TABLE 548 CISCO SYSTEMS, INC.: PRODUCT/SERVICE/SOLUTION ENHANCEMENTS 426

TABLE 549 CISCO SYSTEMS, INC.: DEALS 427

13.1.2 ORACLE 428

TABLE 550 ORACLE: COMPANY OVERVIEW 428

FIGURE 44 ORACLE: COMPANY SNAPSHOT (2023) 429

TABLE 551 ORACLE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 429

TABLE 552 ORACLE: DEALS 430

13.1.3 BAXTER INTERNATIONAL, INC. (HILL-ROM HOLDINGS, INC.) 432

TABLE 553 BAXTER INTERNATIONAL, INC.: COMPANY OVERVIEW 432

FIGURE 45 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2023) 433

TABLE 554 BAXTER INTERNATIONAL, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 433

TABLE 555 BAXTER INTERNATIONAL, INC.: DEALS 434

13.1.4 AVAYA LLC 435

TABLE 556 AVAYA LLC: COMPANY OVERVIEW 435

TABLE 557 AVAYA LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 435

TABLE 558 AVAYA LLC: PRODUCT/SERVICE/SOLUTION LAUNCHES & ENHANCEMENTS 436

TABLE 559 AVAYA LLC: DEALS 437

13.1.5 SPOK INC. 438

TABLE 560 SPOK, INC.: COMPANY OVERVIEW 438

FIGURE 46 SPOK, INC.: COMPANY SNAPSHOT (2023) 438

TABLE 561 SPOK, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 439

TABLE 562 SPOK, INC.: DEALS 439

13.1.6 ASCOM HOLDING AG 441

TABLE 563 ASCOM HOLDING AG: COMPANY OVERVIEW 441

FIGURE 47 ASCOM HOLDING AG: COMPANY SNAPSHOT (2023) 442

TABLE 564 ASCOM HOLDING AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 443

TABLE 565 ASCOM HOLDING AG: PRODUCT/SERVICE/SOLUTION LAUNCHES 444

TABLE 566 ASCOM HOLDING AG: DEALS 444

13.1.7 VOCERA COMMUNICATIONS (STRYKER CORPORATION) 446

TABLE 567 VOCERA COMMUNICATIONS (STRYKER CORPORATION): COMPANY OVERVIEW 446

FIGURE 48 STRYKER CORPORATION: COMPANY SNAPSHOT (2023) 447

TABLE 568 VOCERA COMMUNICATIONS (STRYKER CORPORATION): PRODUCTS/SERVICES/SOLUTIONS OFFERED 447

TABLE 569 VOCERA COMMUNICATIONS (STRYKER CORPORATION): PRODUCT/SERVICE/SOLUTION LAUNCHES 448

TABLE 570 VOCERA COMMUNICATIONS (STRYKER CORPORATION): DEALS 449

13.1.8 MICROSOFT 450

TABLE 571 MICROSOFT: COMPANY OVERVIEW 450

FIGURE 49 MICROSOFT: COMPANY SNAPSHOT (2023) 451

TABLE 572 MICROSOFT: PRODUCTS/SERVICES/SOLUTIONS OFFERED 451

TABLE 573 MICROSOFT: PRODUCT/SERVICE/SOLUTION LAUNCHES 452

TABLE 574 MICROSOFT: DEALS 452

13.1.9 SYMPLR 453

TABLE 575 SYMPLR: COMPANY OVERVIEW 453

TABLE 576 SYMPLR: PRODUCTS/SERVICES/SOLUTIONS OFFERED 453

TABLE 577 SYMPLR: DEALS 454

13.1.10 NEC CORPORATION 455

TABLE 578 NEC CORPORATION: COMPANY OVERVIEW 455

FIGURE 50 NEC CORPORATION: COMPANY SNAPSHOT (2023) 455

TABLE 579 NEC CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 456

13.1.11 EVERBRIDGE, INC. 457

TABLE 580 EVERBRIDGE, INC.: COMPANY OVERVIEW 457

FIGURE 51 EVERBRIDGE, INC.: COMPANY SNAPSHOT (2023) 458

TABLE 581 EVERBRIDGE, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 458

13.1.12 HIDDEN BRAINS INFOTECH 459

TABLE 582 HIDDEN BRAINS INFOTECH: COMPANY OVERVIEW 459

TABLE 583 HIDDEN BRAINS INFOTECH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 459

13.1.13 IMPRIVATA, INC. 460

TABLE 584 IMPRIVATA, INC.: COMPANY OVERVIEW 460

TABLE 585 IMPRIVATA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 460

13.1.14 COMMUNICARE TECHNOLOGY, INC. D/B/A PULSARA 461

TABLE 586 COMMUNICARE TECHNOLOGY, INC. D/B/A PULSARA: COMPANY OVERVIEW 461

TABLE 587 COMMUNICARE TECHNOLOGY, INC. D/B/A PULSARA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 461

TABLE 588 COMMUNICARE TECHNOLOGY, INC. D/B/A PULSARA: DEALS 462

13.1.15 MOBILE HEARTBEAT 463

TABLE 589 MOBILE HEARTBEAT: COMPANY OVERVIEW 463

TABLE 590 MOBILE HEARTBEAT.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 463

TABLE 591 MOBILE HEARTBEAT: DEALS 464

13.1.16 ONPAGE 465

TABLE 592 ONPAGE.: COMPANY OVERVIEW 465

TABLE 593 ONPAGE.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 465

13.1.17 HARRIS ONPOINT 466

TABLE 594 HARRIS ONPOINT: COMPANY OVERVIEW 466

TABLE 595 HARRIS ONPOINT: PRODUCTS/SERVICES/SOLUTIONS OFFERED 466

13.1.18 JIVE SOFTWARE, LLC 467

TABLE 596 JIVE SOFTWARE, LLC: COMPANY OVERVIEW 467

TABLE 597 JIVE SOFTWARE, LLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 467

13.2 OTHER PLAYERS 468

13.2.1 TIGERCONNECT 468

TABLE 598 TIGERCONNECT: COMPANY OVERVIEW 468

13.2.2 JCT HEALTHCARE PTY LTD. 468

TABLE 599 JCT HEALTHCARE PTY LTD.: COMPANY OVERVIEW 468

13.2.3 AMPLION 469

TABLE 600 AMPLION: COMPANY OVERVIEW 469

13.2.4 ANDORHEALTH 469

TABLE 601 ANDORHEALTH: COMPANY OVERVIEW 469

13.2.5 PERFECTSERVE, INC. 470

TABLE 602 PERFECTSERVE, INC.: COMPANY OVERVIEW 470

13.2.6 QLIQSOFT, INC. 470

TABLE 603 QLIQSOFT, INC.: COMPANY OVERVIEW 470

13.2.7 CONNEXALL, GLOBESTAR SYSTEMS INC. 471

TABLE 604 CONNEXALL, GLOBESTAR SYSTEMS INC.: COMPANY OVERVIEW 471

*Details on Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX 472

14.1 DISCUSSION GUIDE 472

14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 478

14.3 CUSTOMIZATION OPTIONS 480

14.4 RELATED REPORTS 480

14.5 AUTHOR DETAILS 481

Market Research Future 価格表
シングルユーザライセンス	USD 4,950
エンタープライズライセンス	USD 7,250

Market Research Future 価格表
シングルユーザライセンス	USD 2,950
エンタープライズライセンス	USD 5,250

ライセンス別の価格
シングルユーザライセンス	USD 1,100
コーポレートライセンス	USD 1,500

ライセンス別の価格
シングルユーザライセンス	USD 1,600
コーポレートライセンス	USD 2,200

ライセンス別の価格
シングルユーザライセンス	USD 5,500
2-5ユーザライセンス	USD 6,600
サイトライセンス	USD 7,920
エンタープライズライセンス	USD 9,504

臨床コミュニケーション＆コラボレーション市場 : 2029年までの世界予測

Clinical Communication & Collaboration Market – Global Forecast to 2029

Report Overview

“Clinical Communication and Collaboration, software segment to witness the highest growth during the forecast period.”

“On-premise model held the largest market share in the Clinical Communication and Collaboration Market .”

“Hospital & Clinics segment to register the highest growth in the Clinical Communication and Collaboration market during the forecast period.”

“APAC is estimated to register the highest CAGR during the forecast period.”

Breakdown of supply-side primary interviews, by company type, designation, and region:

List of Companies Profiled in the Report

Research Coverage

Reasons to Buy the Report

This report also includes.

Table of Contents

医療・医薬の最新記事8件

ワクチン市場 : 2029年までの世界予測

世界の出生前検査市場

アレルギー診断市場 : 2029年までの世界予測

滅菌装置市場 : 2029年までの世界予測

血液透析＆腹膜透析市場 : 2029年までの世界予測

患者監視装置市場 : 2029年までの世界予測

世界の皮膚アレルギー検査市場

世界の減量薬市場 : 2029年までの予測

ライセンス別の価格
シングルユーザライセンス	USD 3,500
2-5ユーザライセンス	USD 4,200
サイトライセンス	USD 5,040
エンタープライズライセンス	USD 6,048

ライセンス別の価格
シングルユーザライセンス	USD 2,900
コーポレートライセンス	USD 4,500

ライセンス別の価格
シングルユーザ	USD 4,950
マルチユーザ（5名）	USD 6,650
コーポレート	USD 8,150
エンタープライズ	USD10,000